4.7 Article

Deciphering the immune heterogeneity dominated by natural killer cells with prognostic and therapeutic implications in hepatocellular carcinoma

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

webTWAS: a resource for disease candidate susceptibility genes identified by transcriptome-wide association study

Chen Cao et al.

Summary: webTWAS is a new resource that combines comprehensive disease GWAS datasets with information on potential causal genes, allowing researchers to explore gene-disease associations. With data from 1298 high-quality GWAS summary statistics, a total of 235,064 gene-disease associations can be accessed, and custom TWAS analyses can be run on a user-friendly web server.

NUCLEIC ACIDS RESEARCH (2022)

Article Oncology

T and NK cell abundance defines two distinct subgroups of renal cell carcinoma

Moon Hee Lee et al.

Summary: This study investigated the immunological heterogeneity of renal cell carcinoma (RCC) tumors. The results revealed that RCC tumors can be categorized into two subgroups based on the abundance of tumor infiltrating lymphocytes and PD-1 expression on CD8+ T cells, as well as the infiltration of NK cells. Transcriptomic and genomic analysis showed distinct differences between the two subgroups. These findings provide insights into the immunological heterogeneity of RCC and its potential impact on treatment responses to immunological therapies.

ONCOIMMUNOLOGY (2022)

Article Biochemical Research Methods

Comprehensive assessment of cellular senescence in the tumor microenvironment

Xiaoman Wang et al.

Summary: This study quantified cellular senescence levels using computational metrics and explored senescence-related phenotypes in different cancer types and normal tissues. The research found that the cellular senescence scores were associated with genomic and immune characteristics and could significantly predict immunotherapy responses and patient prognosis in various cancers. Single-cell analysis revealed intra-tumor heterogeneity and an activated immune microenvironment in senescent prostate cancer. Machine learning algorithms identified three potential prognostic genes for prostate cancer.

BRIEFINGS IN BIOINFORMATICS (2022)

Article Gastroenterology & Hepatology

A prognostic model for hepatocellular carcinoma patients based on signature ferroptosis-related genes

Sizhe Wan et al.

Summary: An prognostic model based on ferroptosis-related genes was successfully established using RNA-seq and clinical data of HCC patients. The model incorporates risk score, TNM stage, and cirrhosis to predict the survival of HCC patients. The difference in overall survival between risk groups was found to be closely related to immune-related pathways, suggesting that an immune-suppressive tumor microenvironment may influence the prognosis of HCC patients.

HEPATOLOGY INTERNATIONAL (2022)

Article Medicine, Research & Experimental

A gene prognostic index from cellular senescence predicting metastasis and radioresistance for prostate cancer

Dechao Feng et al.

Summary: By establishing a cellular senescence-related gene prognostic index (CSGPI), we found that CSGPI could serve as an effective biomarker predicting metastasis probability and radioresistance for prostate cancer (PCa). We also proposed that immune evasion might be involved in the process of PCa metastasis.

JOURNAL OF TRANSLATIONAL MEDICINE (2022)

Article Medicine, Research & Experimental

Pharmacoepitranscriptomic landscape revealing m6A modification could be a drug-effect biomarker for cancer treatment

Ke Liu et al.

Summary: RNA chemical modifications play a significant role in RNA splicing, transport, stability, and translation. This article focuses on the correlation between these modifications and drug effects, particularly in the context of pharmacogenes. The study reveals the prevalence of chemical modifications, with a specific emphasis on the N6-methyladenosine (m6A) modification. Furthermore, it highlights the close relationship between chemical modifications and anti-tumor drugs, particularly in triple-negative breast cancer, ovarian cancer, and acute myelocytic leukemia.

MOLECULAR THERAPY-NUCLEIC ACIDS (2022)

Article Immunology

Comprehensive Analysis of a Cancer-Immunity Cycle-Based Signature for Predicting Prognosis and Immunotherapy Response in Patients With Colorectal Cancer

Yufang Hou et al.

Summary: In this study, a cancer-immunity cycle-based signature was developed to predict the prognosis and efficacy of immunotherapy for colorectal cancer patients. Low-risk patients showed better prognosis and stronger response to immunotherapy.

FRONTIERS IN IMMUNOLOGY (2022)

Article Multidisciplinary Sciences

Liver tumour immune microenvironment subtypes and neutrophil heterogeneity

Ruidong Xue et al.

Summary: This study used single-cell RNA sequencing analysis to investigate the heterogeneity of the tumour immune microenvironment (TIME) in liver cancer. The researchers identified five TIME subtypes and found that tumour-associated neutrophil (TAN) populations enriched in the myeloid-cell-enriched subtype were associated with an unfavourable prognosis. They also demonstrated that CCL4(+) TANs can recruit macrophages and that PD-L1(+) TANs can suppress T cell cytotoxicity. Mouse models confirmed the pro-tumour phenotypes of TANs. This study provides insights into the immunosuppressive functions of TANs and highlights their potential as targets for immunotherapies.

NATURE (2022)

Review Biochemistry & Molecular Biology

Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications

Brent R. Stockwell

Summary: This review describes the key regulators of ferroptosis and provides an overview of metabolism, ROS biology, and iron biology. Additionally, it highlights the important concepts and unanswered questions in the field of ferroptosis. The future holds promise for further breakthroughs in understanding the mechanisms of ferroptosis and utilizing it for therapeutic purposes.
Article Multidisciplinary Sciences

Pan-cancer single-cell analysis reveals the heterogeneity and plasticity of cancer-associated fibroblasts in the tumor microenvironment

Han Luo et al.

Summary: This study conducts pan-cancer analysis on 226 samples across 10 solid cancer types, illustrating the commonalities and plasticity of heterogeneous CAFs. It reveals that the activation trajectory of major CAF types is divided into three states, showing distinct interactions with other cell components and correlation with immunotherapy prognosis. Additionally, minor CAF components may originate from other TME components such as endothelial cells and macrophages.

NATURE COMMUNICATIONS (2022)

Article Biochemistry & Molecular Biology

Characterization of cellular senescence patterns predicts the prognosis and therapeutic response of hepatocellular carcinoma

Yuqin Tang et al.

Summary: Two hepatocellular carcinoma subtypes were identified using prognostic cellular senescence-related genes, and a prognostic scoring system was constructed to predict survival outcomes and therapeutic response sensitivity.

FRONTIERS IN MOLECULAR BIOSCIENCES (2022)

Article Immunology

Hallmark-guided subtypes of hepatocellular carcinoma for the identification of immune-related gene classifiers in the prediction of prognosis, treatment efficacy, and drug candidates

Chengbin Guo et al.

Summary: This study comprehensively evaluated the prognosis of hepatocellular carcinoma (HCC) patients and identified two HCC subtypes with distinct prognostic outcomes. A novel prognostic gene signature based on immune-related genes was constructed, providing a helpful guide for clinicians. The study also explored the mutational landscapes and immune profiles of different risk groups and predicted potential drug candidates for HCC.

FRONTIERS IN IMMUNOLOGY (2022)

Article Biology

Identification of cuproptosis-related subtypes, establishment of a prognostic model and tumor immune landscape in endometrial carcinoma

Jingsong Shan et al.

Summary: Cuproptosis, a mechanism of copper-dependent cell death, has the potential to be a new treatment for tumors resistant to conventional therapies. By analyzing changes in cuproptosis-related genes in endometrial cancer cohorts, three distinct gene clusters were identified, with patients in one cluster having higher survival probability and tumor microenvironment cell infiltration levels. A risk scoring system based on these genes can stratify patients into high-risk and low-risk groups, where low-risk patients have better prognosis and immunotherapy efficacy. Furthermore, the gene scores are correlated with other indicators such as copy number variation and tumor mutation load.

COMPUTERS IN BIOLOGY AND MEDICINE (2022)

Article Biology

Integrated transcriptomics unravels implications of glycosylation-regulating signature in diagnosis, prognosis and therapeutic benefits of hepatocellular carcinoma

Hua Tang et al.

Summary: This study provides comprehensive insights into the diagnostic and prognostic stratification of HCC based on integrated glycosylation-regulating signature. The robust glycosylation scoring system effectively evaluates TME traits, predicts prognosis, and clinical benefits from neoadjuvant therapies. It also demonstrates the potential for promoting personalized clinical decision-making.

COMPUTERS IN BIOLOGY AND MEDICINE (2022)

Article Immunology

Heterogeneity in NK Cell Subpopulations May Be Involved in Kidney Cancer Metastasis

Zhengfang Liang et al.

Summary: This study revealed heterogeneity in infiltrating NK cells of kidney cancer, identifying three subpopulations based on gene expression profiles. It was found that NK (EGR1) and NK (CAPG) were closely related to tumor metastasis, providing potential targets for inhibiting metastasis in clear cell renal cell carcinoma.

JOURNAL OF IMMUNOLOGY RESEARCH (2022)

Article Immunology

Cuproptosis-related modification patterns depict the tumor microenvironment, precision immunotherapy, and prognosis of kidney renal clear cell carcinoma

Zhiyong Cai et al.

Summary: Two distinct cuproptosis-related patterns were identified, with different impacts on prognosis and immune cell infiltration in kidney renal clear cell carcinoma (KIRC). The cuproptosis signature and risk score can guide precision therapy and accurate prognosis prediction for KIRC patients, exhibiting excellent prediction accuracy for survival outcomes.

FRONTIERS IN IMMUNOLOGY (2022)

Article Immunology

Natural killer cell-related prognosis signature characterizes immune landscape and predicts prognosis of HNSCC

Hao Chi et al.

Summary: This study established a reliable signature based on genes related to NK cells in HNSCC, providing a new perspective for assessing immunotherapy response and prognosis. The 17-NRGs signature demonstrated excellent predictive performance and offered new perspectives for evaluating pre-immune efficacy, facilitating future precision immuno-oncology research.

FRONTIERS IN IMMUNOLOGY (2022)

Article Multidisciplinary Sciences

Deep learning reveals predictive sequence concepts within immune repertoires to immunotherapy

John-William Sidhom et al.

Summary: The DeepTCR framework, which employs deep learning algorithms, can predict response to immunotherapy by uncovering sequence concepts and inferring antigenic specificities of predictive signatures. Nonresponse is associated with high frequencies of tumor-specific TCRs that undergo dynamic changes during therapy, potentially due to the dysfunctional state of these T cells.

SCIENCE ADVANCES (2022)

Article Oncology

High-resolution single-cell atlas reveals diversity and plasticity of tissue-resident neutrophils in non-small cell lung cancer

Stefan Salcher et al.

Summary: This study investigates the immune cell phenotypes in non-small cell lung cancer (NSCLC) and identifies cellular components associated with tumor histology and genotypes. The study also reveals the plasticity of tissue-resident neutrophils (TRNs) and their association with anti-programmed cell death ligand 1 (PD-L1) treatment failure.

CANCER CELL (2022)

Article Immunology

Pyroptosis predicts immunotherapy outcomes across multiple cancer types

Song Li et al.

Summary: This study evaluated the impact of Pyroptosis potential in cancer patients and found that high potential is associated with tumor characteristics and response rates to immunotherapy. Pyroptosis scoring showed predictive value in immunotherapy outcomes. Additionally, systemic treatments can enhance Pyroptosis in drug-resistant tumors.

CLINICAL IMMUNOLOGY (2022)

Review Oncology

Natural killer cells in antitumour adoptive cell immunotherapy

Tamara J. Laskowski et al.

Summary: This review provides an overview of NK cell-based immunotherapies, discussing strategies to increase NK cell cytotoxicity and persistence and highlighting the current challenges and future opportunities for the design of next-generation NK cell therapies.

NATURE REVIEWS CANCER (2022)

Article Medicine, Research & Experimental

N6-methyladenosine-associated prognostic pseudogenes contribute to predicting immunotherapy benefits and therapeutic agents in head and neck squamous cell carcinoma

Liqiang Tan et al.

Summary: The study found that m6A-associated pseudogenes are significantly correlated with infiltrating immune cell compositions and the expression of antitumor immune response markers. These pseudogenes can regulate the expression of targeted immune-involved genes through miRNAs. HNSCC patients in the high-risk subtype may benefit more from immune checkpoint inhibitors therapy. In vitro experiments confirmed that doxorubicin and topotecan could be the most promising therapeutic options for HNSCC patients in the high-risk subtype.

THERANOSTICS (2022)

Article Biochemistry & Molecular Biology

Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma

Yunfan Sun et al.

Summary: This study showed that early-relapse hepatocellular carcinoma (HCC) tumors exhibit innate-like CD8(+) T cells with overexpression of KLRB1 (CD161) and a low cytotoxic state, unlike the exhausted state seen in primary HCC. These cells were associated with a worse prognosis. Additionally, potential immune evasion mechanisms were identified in recurrent tumor cells, which dampen dendritic cell antigen presentation and recruit innate-like CD8(+) T cells.
Article Oncology

Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer

Yuanyuan Zhang et al.

Summary: The study indicates that high levels of baseline CXCL13(+) T cells are associated with effective responses to combination therapy in triple-negative breast cancer patients. These cells increase following combination therapy but decrease after monotherapy, highlighting their importance in predicting treatment outcomes.

CANCER CELL (2021)

Article Medicine, General & Internal

Hepatocellular carcinoma

Josep M. Llovet et al.

Summary: Liver cancer, particularly hepatocellular carcinoma (HCC), poses a significant global health challenge with rising incidence projected to exceed 1 million cases by 2025. Infection by hepatitis B and C viruses remains a major risk factor for HCC, while non-alcoholic steatohepatitis is emerging as a more common risk factor in Western countries. Advances in systemic therapies for HCC, including immunotherapies and targeted therapies, are expected to revolutionize the management of this disease.

NATURE REVIEWS DISEASE PRIMERS (2021)

Article Multidisciplinary Sciences

Tumor immunological phenotype signature-based high-throughput screening for the discovery of combination immunotherapy compounds

Haiyan Wang et al.

Summary: Combination immunotherapy using AKIs has been found to reprogram TIP gene expression, promote T cell infiltration in TNBC, and enhance the efficacy of PD-1, suggesting a novel strategy for discovering combination immunotherapy compounds.

SCIENCE ADVANCES (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Immunology

Germline genetic contribution to the immune landscape of cancer

Rosalyn W. Sayaman et al.

Summary: Understanding the host's genetic background's contribution to cancer immunity has significant impact on the composition and functional orientation of the tumor immune microenvironment, with certain genes potentially acting as immune modulators. Investigating the effects of germline variants on immune traits provides a resource toward further understanding tumor-immune interactions.

IMMUNITY (2021)

Article Biochemistry & Molecular Biology

Turning up the heat on non-immunoreactive tumors: pyroptosis influences the tumor immune microenvironment in bladder cancer

Xingyu Chen et al.

Summary: Research shows a significant correlation between the expression imbalance of pyroptosis-related molecules and genome variation in various cancers, indicating an important role of pyroptosis in shaping the tumor microenvironment. Evaluating pyroptosis modification patterns enhances understanding of tumor microenvironment infiltration and can guide more effective immunotherapy strategies.

ONCOGENE (2021)

Review Oncology

Broadening horizons: the role of ferroptosis in cancer

Xin Chen et al.

Summary: Ferroptosis is an iron-dependent form of regulated cell death driven by excessive lipid peroxidation, and can be induced by various agents to suppress tumor growth while also potentially triggering inflammation-associated immunosuppression. The extent of ferroptosis's impact on tumor biology and its interactions with other signaling pathways are still under investigation.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

Article Biochemical Research Methods

A new thinking: extended application of genomic selection to screen multiomics data for development of novel hypoxia-immune biomarkers and target therapy of clear cell renal cell carcinoma

Cheng-Peng Gui et al.

Summary: This study explored the interaction between hypoxia and immune in the ccRCC microenvironment using multiomics data and established a satisfying prognostic model with important prognostic genes identified. Additionally, high-risk patients were found to show better responses to immunotherapy and chemotherapy drugs, indicating potential implications for personalized treatment strategies.

BRIEFINGS IN BIOINFORMATICS (2021)

Article Biochemistry & Molecular Biology

Comprehensive analyses of m6A regulators and interactive coding and non-coding RNAs across 32 cancer types

Sipeng Shen et al.

Summary: N6-methyladenosine (m6A) modification plays important roles in the development of cancers by interacting with coding and non-coding RNAs. This study identified three distinct m6A modification subtypes and constructed an individual-level m6A signature, which was associated with tumor microenvironment cell infiltration degrees and overall survival in various cancer types.

MOLECULAR CANCER (2021)

Review Gastroenterology & Hepatology

Advances in immunotherapy for hepatocellular carcinoma

Bruno Sangro et al.

Summary: Immunotherapeutic interventions have shown effectiveness in the treatment of hepatocellular carcinoma. Checkpoint inhibitors have demonstrated strong anti-tumor activity, but other immune strategies have not yet shown consistent clinical activity. Advancing treatment to earlier stages, discovering predictive biomarkers, and exploring effective combinatorial approaches are key challenges in HCC immunotherapy.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)

Article Medicine, Research & Experimental

Genomic analysis uncovers prognostic and immunogenic characteristics of ferroptosis for clear cell renal cell carcinoma

Dan Bai et al.

Summary: This study systematically investigated the characteristic patterns of ferroptosis in ccRCC and its interactions with the tumor microenvironment. High ferroptosis scores were associated with poor prognosis, increased T cell infiltration, elevated immune and stromal scores, and enhanced response to anti-CTLA4 immunotherapy, while low ferroptosis scores were linked to enhanced tumor purity and amino acid and fatty acid metabolism pathways. Evaluation of ferroptosis patterns may help oncologists develop personalized immunotherapeutic strategies.

MOLECULAR THERAPY-NUCLEIC ACIDS (2021)

Review Oncology

Pyroptosis at the forefront of anticancer immunity

Reid Loveless et al.

Summary: Pyroptosis, a lytic and inflammatory programmed cell death pathway, has shown potential in addressing tumor resistance to apoptosis and the immunosuppressive tumor microenvironment by inducing a robust inflammatory response and marked tumor regression. Gasdermin proteins mediate pyroptosis and facilitate immune cell activation and infiltration, but aberrant pyroptosis may also contribute to tumor progression by upregulating gasdermin proteins in certain cancers. Harnessing pyroptosis as a tool in anticancer strategies shows promise in novel interventions.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

Review Oncology

Spatial architecture of the immune microenvironment orchestrates tumor immunity and therapeutic response

Tong Fu et al.

Summary: Tumors are not only collections of malignant cells, but also organized complex ecosystems. With the emergence of innovative technologies, researchers can more accurately understand the spatial architecture of the tumor immune microenvironment (TIME), improving our knowledge of tumor biology. The spatial architecture of TIME plays a crucial role in tumor biology and is influenced by the gradient of extracellular nonspecific chemicals (ENSCs).

JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)

Article Gastroenterology & Hepatology

CheckMate 040 cohort 5: A phase I/II study of nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh B cirrhosis

Masatoshi Kudo et al.

Summary: Nivolumab monotherapy showed clinical activity and favorable safety in patients with Child-Pugh B status aHCC, with manageable treatment-related adverse events, suggesting its suitability for this patient population.

JOURNAL OF HEPATOLOGY (2021)

Article Medicine, Research & Experimental

An immunogenomic signature for molecular classification in hepatocellular carcinoma

Weiwei Zhuang et al.

Summary: This study investigated molecular classification and prognostic value in hepatocellular carcinoma (HCC) based on immune signature. Three HCC subtypes were identified, with Immunity_H subtype showing better survival rate. IL18RAP and IL7R were protective genes, and immune risk score was an independent risk factor for overall survival in HCC patients.

MOLECULAR THERAPY-NUCLEIC ACIDS (2021)

Article Medicine, General & Internal

A glycosyltransferase gene signature to detect pancreatic ductal adenocarcinoma patients with poor prognosis

Yousra Mohamed Abd-El-Halim et al.

Summary: The study identified a novel stratification of PDAC based on glycosyltransferase expression profiles, showing distinct clinical outcomes with prognostic value. This glyco-signature may serve as a potential prognostic tool and offer new therapeutic targets for resected and unresectable PDAC patients.

EBIOMEDICINE (2021)

Article Multidisciplinary Sciences

Combination of epigenetic regulation with gene therapy-mediated immune checkpoint blockade induces anti-tumour effects and immune response in vivo

Huapan Fang et al.

Summary: While immunotherapy has shown promise as a cancer treatment, durable benefits are often limited by immune escape mechanisms. This study combines epigenetic regulation with gene therapy for immune checkpoint blockade to enhance anti-tumor effects and immune responses in vivo, providing a potential strategy for tumor treatment and prevention of relapse and metastasis.

NATURE COMMUNICATIONS (2021)

Article Oncology

Characterization of immune landscape in papillary thyroid cancer reveals distinct tumor immunogenicity and implications for immunotherapy

Jing Sun et al.

Summary: This study investigated the immune landscape in PTC and established a prognostic immune-related signature (IRS) for predicting progression-free survival (PFS). A survival decision tree and scoring nomogram were constructed to improve prognostic stratification and predictive accuracy. Analysis of altered pathways, mutational patterns, and potential drugs in different immune-related risk groups was also conducted.

ONCOIMMUNOLOGY (2021)

Article Biochemistry & Molecular Biology

Employing hypoxia characterization to predict tumour immune microenvironment, treatment sensitivity and prognosis in hepatocellular carcinoma

Fanhong Zeng et al.

Summary: The hypoxic microenvironment plays a crucial role in driving the malignant phenotype in hepatocellular carcinoma and modulating tumor immune microenvironment remodeling. Understanding the relationship between hypoxia and tumor progression can provide insights for improving treatment and prognosis. A hypoxia risk model based on four hypoxia-related genes has been developed to predict treatment sensitivity and outcomes in HCC patients.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)

Review Biochemistry & Molecular Biology

The role of m6A modification in the biological functions and diseases

Xiulin Jiang et al.

Summary: This paper highlights the importance of m6A RNA modification in eukaryotic RNA, including the roles of m6A methyltransferases, demethylases, and binding proteins. It emphasizes the crucial role of m6A RNA modification in the development of human cancers and discusses its impact on the physiological and pathological progressions of hematopoietic, central nervous, and reproductive systems.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Article Medicine, Research & Experimental

Identification and validation of hypoxia-derived gene signatures to predict clinical outcomes and therapeutic responses in stage I lung adenocarcinoma patients

Run Shi et al.

Summary: By analyzing data from 1,400 stage I LUAD patients from 14 public datasets, this study established hypoxia-derived signatures for predicting overall survival and immune checkpoint blockade therapy response in patients with stage I lung adenocarcinoma. The hypoxia-related prognostic risk score showed stronger predictive capacity than traditional clinicopathological features, and the hypoxia-related immunotherapeutic response score outperformed conventional biomarkers for ICB therapy.

THERANOSTICS (2021)

Article Medicine, Research & Experimental

Siglec15 shapes a non-inflamed tumor microenvironment and predicts the molecular subtype in bladder cancer

Jiao Hu et al.

Summary: Siglec15 is specifically overexpressed in the tumor microenvironment (TME) of various cancers, likely designing a non-inflamed TME in bladder cancer (BLCA). High expression of Siglec15 in BLCA correlates with lower immune infiltration, lower response to cancer immunotherapy, and a higher incidence of hyperprogression. A combination of anti-Siglec15 and cancer immunotherapy may be a more effective strategy than monotherapy, while an immune risk score (IRS) could accurately predict prognosis and response to treatment.

THERANOSTICS (2021)

Article Medicine, Research & Experimental

Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma

Zheng Wang et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2020)

Review Gastroenterology & Hepatology

Tumour evolution in hepatocellular carcinoma

Amanda J. Craig et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)

Review Oncology

Intratumor Heterogeneity: The Rosetta Stone of Therapy Resistance

Andriy Marusyk et al.

CANCER CELL (2020)

Article Reproductive Biology

Integrated analysis of gene expression and DNA methylation profiles in ovarian cancer

Guanghui Gong et al.

JOURNAL OF OVARIAN RESEARCH (2020)

Article Medicine, General & Internal

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma

Richard S. Finn et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Biochemistry & Molecular Biology

Immune-based therapies for hepatocellular carcinoma

David J. Pinato et al.

ONCOGENE (2020)

Article Biochemistry & Molecular Biology

The Ubiquitin Gene Expression Pattern and Sensitivity toUBBandUBCKnockdown Differentiate Primary 23132/87 and Metastatic MKN45 Gastric Cancer Cells

Emanuele Salvatore Scarpa et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Biochemistry & Molecular Biology

Immune checkpoint molecules in natural killer cells as potential targets for cancer immunotherapy

Yuqing Cao et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Article Medicine, Research & Experimental

A novel nucleolin-binding peptide for Cancer Theranostics

Jae-Hyun Kim et al.

THERANOSTICS (2020)

Article Biochemistry & Molecular Biology

A Novel Ferroptosis-related Gene Signature for Overall Survival Prediction in Patients with Hepatocellular Carcinoma

Jie-ying Liang et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)

Article Biochemical Research Methods

TISIDB: an integrated repository portal for tumor-immune system interactions

Beibei Ru et al.

BIOINFORMATICS (2019)

Article Biochemistry & Molecular Biology

Molecular characterization and clinical relevance of m6A regulators across 33 cancer types

Yongsheng Li et al.

MOLECULAR CANCER (2019)

Review Gastroenterology & Hepatology

A global view of hepatocellular carcinoma: trends, risk, prevention and management

Ju Dong Yang et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)

Article Biochemistry & Molecular Biology

Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma

Qiming Zhang et al.

Article Multidisciplinary Sciences

Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial

Derin B. Keskin et al.

NATURE (2019)

Article Genetics & Heredity

Tumor mutational load predicts survival after immunotherapy across multiple cancer types

Robert M. Samstein et al.

NATURE GENETICS (2019)

Article Gastroenterology & Hepatology

Projections of primary liver cancer to 2030 in 30 countries worldwide

Patricia C. Valery et al.

HEPATOLOGY (2018)

Article Biochemistry & Molecular Biology

Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation

Tathiane M. Malta et al.

Article Immunology

The Immune Landscape of Cancer

Vesteinn Thorsson et al.

IMMUNITY (2018)

Article Biotechnology & Applied Microbiology

Integrating single-cell transcriptomic data across different conditions, technologies, and species

Andrew Butler et al.

NATURE BIOTECHNOLOGY (2018)

Review Immunology

The immunology of hepatocellular carcinoma

Marc Ringelhan et al.

NATURE IMMUNOLOGY (2018)

Article Biochemistry & Molecular Biology

Phenotype molding of stromal cells in the lung tumor microenvironment

Diether Lambrechts et al.

NATURE MEDICINE (2018)

Article Biochemistry & Molecular Biology

A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments

Kevin C. Barry et al.

NATURE MEDICINE (2018)

Review Cell Biology

Hallmarks of Cellular Senescence

Alejandra Hernandez-Segura et al.

TRENDS IN CELL BIOLOGY (2018)

Article Oncology

TIP: A Web Server for Resolving Tumor Immunophenotype Profiling

Liwen Xu et al.

CANCER RESEARCH (2018)

Article Multidisciplinary Sciences

TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells

Sanjeev Mariathasan et al.

NATURE (2018)

Article Biochemistry & Molecular Biology

Maftools: efficient and comprehensive analysis of somatic variants in cancer

Anand Mayakonda et al.

GENOME RESEARCH (2018)

Article Oncology

Immune Cytolytic Activity Stratifies Molecular Subsets of Human Pancreatic Cancer

David Balli et al.

CLINICAL CANCER RESEARCH (2017)

Editorial Material Medicine, General & Internal

Tragedy, Perseverance, and Chance - The Story of CAR-T Therapy

Lisa Rosenbaum

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Genetics & Heredity

Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden

Zachary R. Chalmers et al.

GENOME MEDICINE (2017)

Article Biochemistry & Molecular Biology

Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab

Nadeem Riaz et al.

Article Biochemistry & Molecular Biology

Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing

Chunhong Zheng et al.

Article Biochemistry & Molecular Biology

TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data

Antonio Colaprico et al.

NUCLEIC ACIDS RESEARCH (2016)

Article Oncology

Cold-inducible RNA-binding protein promotes the development of liver cancer

Toshiharu Sakurai et al.

CANCER SCIENCE (2015)

Article Biochemistry & Molecular Biology

Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity

Michael S. Rooney et al.

Article Gastroenterology & Hepatology

World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma

Catherine de Martel et al.

HEPATOLOGY (2015)

Article Biochemistry & Molecular Biology

NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma

Aaron P. Rapoport et al.

NATURE MEDICINE (2015)

Article Biochemistry & Molecular Biology

limma powers differential expression analyses for RNA-sequencing and microarray studies

Matthew E. Ritchie et al.

NUCLEIC ACIDS RESEARCH (2015)

Article Biochemistry & Molecular Biology

The Molecular Signatures Database Hallmark Gene Set Collection

Arthur Liberzon et al.

CELL SYSTEMS (2015)

Article Oncology

CTLA4 Blockade Broadens the Peripheral T-Cell Receptor Repertoire

Lidia Robert et al.

CLINICAL CANCER RESEARCH (2014)

Article Biochemical Research Methods

GSVA: gene set variation analysis for microarray and RNA-Seq data

Sonja Haenzelmann et al.

BMC BIOINFORMATICS (2013)

Review Immunology

Oncology Meets Immunology: The Cancer-Immunity Cycle

Daniel S. Chen et al.

IMMUNITY (2013)

Article Immunology

Identification of SERPINB1 As a Physiological Inhibitor of Human Granzyme H

Li Wang et al.

JOURNAL OF IMMUNOLOGY (2013)

Article Multidisciplinary Sciences

Inferring tumour purity and stromal and immune cell admixture from expression data

Kosuke Yoshihara et al.

NATURE COMMUNICATIONS (2013)

Article Biotechnology & Applied Microbiology

clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters

Guangchuang Yu et al.

OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)

Article Biochemical Research Methods

ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking

Matthew D. Wilkerson et al.

BIOINFORMATICS (2010)

Article Multidisciplinary Sciences

Cancer regression in patients after transfer of genetically engineered lymphocytes

Richard A. Morgan et al.

SCIENCE (2006)

Review Immunology

NK cell recognition

LL Lanier

ANNUAL REVIEW OF IMMUNOLOGY (2005)

Article Cell Biology

A Role for Plk1 phosphorylation of NudC in cytokinesis

T Zhou et al.

DEVELOPMENTAL CELL (2003)